Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zengtong Zhou is active.

Publication


Featured researches published by Zengtong Zhou.


PLOS ONE | 2012

Oral Cancer Development in Patients with Leukoplakia – Clinicopathological Factors Affecting Outcome

Wei Liu; Linjun Shi; Lan Wu; Jinqiu Feng; Xi Yang; Jiang Li; Zengtong Zhou; Chenping Zhang

Background Oral leukoplakia (OL) is the best-known potentially malignant disorder. The objective of the current study was to evaluate the clinicopathological factors predictive of outcome in a large cohort of patients with OL, and report our experience in the early detection of malignant events. Methods A total of 320 patients with biopsy-proven OL were retrospectively reviewed from the study institution who had a mean follow-up of 5.1 years. Data on patient and lesion at initial diagnosis and patient underwent sequential biopsies were reviewed. Multiple biopsies indicates > = 3 times sequential biopsies. Oral cancer-free survival rate (OCFS) was determined by the Kaplan-Meier method and significant factors were identified by Cox regression analysis. Results The 3-year and 5-year OCFS was 86.6% and 82.0%, respectively. A new binary system of grading oral dysplasia was performed and Kaplan-Meier analysis indicated that high-grade dysplasia had significantly higher malignant incidence than low-grade dysplasia (5-year OCFS, 90.5% vs 59.0%; P<0.001), especially during the first 2–3 years of follow-up. Multivariate analysis revealed that the 4 factors including patient aged >60 years, lesion located at lateral/ventral tongue, non-homogenous lesion, high-grade dysplasia were independent significant indicators for OL malignant transformation. In addition, significant positive correlation between the multiple biopsies and these 4 factors and malignant outcome was established. Conclusions Elderly patients with OL located at lateral/ventral tongue and who had non-homogenous lesion with high-grade dysplasia correlated much higher risk of transformation. This high-risk subpopulation was suggested to undergo sequential biopsies and histologic examination contributing to early detection of malignant event.


PLOS ONE | 2012

Upregulation of miR-31* Is Negatively Associated with Recurrent/Newly Formed Oral Leukoplakia

Wen Xiao; Zhe-Xuan Bao; Chen‐Yang Zhang; Xiao-Yun Zhang; Linjun Shi; Zengtong Zhou; Wei-Wen Jiang

Background Oral leukoplakia (OLK) is a potentially malignant disorder of the oral cavity. However, the underlying mechanism of OLK is still unclear. In this study, we explore possible miRNAs involved in OLK. Methodology/Principal Findings Using miRNA microarrays, we profiled miRNA expression in OLK and malignantly transformed OLK (mtOLK) tissue samples. The upregulation of miR-31*, miR-142-5p, miR-33a, miR-1259, miR-146b-5p, miR-886-3p, miR-886-5p, miR-519d, and miR-301a along with the downregulation of miR-572, miR-611, miR-602, miR-675, miR-585, miR-623, miR-637, and miR-1184 in mtOLK were new observations. Fluorescence in situ hybridization (FISH) analyses confirmed that miR-31* is highly expressed in mtOLK. There was a significant difference between the FISH score (p<0.05) in patients with or without recurrent/newly formed OLK. Functional analyses demonstrated that a miR-31* inhibitor decreased apoptosis in the Leuk-1, which is an immortalized oral epithelial cell line spontaneously derived from an oral leukoplakia lesion. miR-31* regulated apoptosis, cell proliferation, migration, and invasion in the HOIEC, which is a HPV E6/E7-immortalized oral epithelial cell line. Furthermore, miR-31* modulated the biological functions of apoptosis, cell proliferation, cell cycle, migration, and invasion in the oral squamous cell carcinoma cell line, Cal-27. Using bioinformatic analyses and dual luciferase reporter assays, we determined that the 3′ untranslated region of fibroblast growth factor 3 (FGF3) is the target of miR-31*. Expression of FGF3 was downregulated or upregulated in the presence of a miR-31* mimic or inhibitor, respectively. Conclusions/Significance Upregulation of miR-31* is negatively associated with recurrent/newly formed OLK. MiR-31* may exert similar but distinguishable effects on biological function in oral cells with different malignant potential. FGF3 is the target of miR-31*. miR-31* may play an important role during OLK progression through regulating FGF3. MiRNA* strands may also have prominent roles in oral carcinogenesis.


Cancer Epidemiology, Biomarkers & Prevention | 2010

Podoplanin and ABCG2: Malignant Transformation Risk Markers for Oral Lichen Planus

Peng Shi; Wei Liu; Zengtong Zhou; Qing-Bo He; Wei-Wen Jiang

Background: Oral lichen planus (OLP) is a potentially malignant disorder associated with an increased risk for oral cancer. The purpose of this study was to determine protein expression of podoplanin and ATP-binding cassette, G2 subfamily (ABCG2) in patients with OLP and evaluate their use as biomarkers for OLP malignant transformation risk. Methods: Podoplanin and ABCG2 expressions were determined in samples from 110 patients with untransformed OLP and 9 patients with malignant transformed OLP (mean follow-up of 5.1 years). We compared podoplanin expression, ABCG2 expression, and clinicopathologic parameters between the two groups. Results: Podoplanin expression was observed in 48 of 110 (43.6%) cases of untransformed OLP and in 8 of 9 (88.9%) cases of transformed OLP. ABCG2 expression was found in 23 of 110 (20.9%) cases of untransformed OLP and in 6 of 9 (66.7%) cases of transformed OLP. Multivariate regression analysis revealed that podoplanin or ABCG2 expression was associated with 17.13-fold [95% confidence interval (95% CI), 1.71-171.22; P = 0.016] or 6.04-fold (95% CI, 1.20-30.36; P = 0.029) increased risk of malignant transformation, respectively. The risk of OLP malignant transformation was considerably higher with coexpression of podoplanin and ABCG2 than without coexpression of podoplanin and ABCG2 (odds ratio, 25.24; 95% CI, 4.48-142.27; P < 0.001). Conclusions: The expressions of podoplanin and ABCG2 in OLP were significantly associated with malignant transformation risk. Impact: Our data suggested that podoplanin and ABCG2 may be used as biomarkers for risk assessment of oral malignant transformation in patients with OLP. Cancer Epidemiol Biomarkers Prev; 19(3); 844–9


Cancer | 2012

Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.

Wei Liu; Jinqiu Feng; Xuemin Shen; Hai‐Yan Wang; Yang Liu; Zengtong Zhou

Although oral leukoplakia (OL) is the best‐known potentially malignant disorder, the risk of OL malignant transformation is difficult to assess. ATP‐binding cassette, G2 subfamily (ABCG2) and BMI‐1 are stem cell markers that have been found to be associated with head and neck tumorigenesis. The objective of the current study was to evaluate the usefulness of ABCG2 and BMI‐1 in predicting OL transformation.


Histopathology | 2011

Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases.

Wei Liu; Zhe-Xuan Bao; Linjun Shi; Guoyao Tang; Zengtong Zhou

Liu W, Bao Z‐X, Shi L‐J, Tang G‐Y & Zhou Z‐T 
(2011) Histopathology ;59, 733–740


International Journal of Cancer | 2013

Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.

Wei Liu; Lan Wu; Xuemin Shen; Linjun Shi; Chenping Zhang; Li-Qun Xu; Zengtong Zhou

Molecular markers for predicting oral cancer development in premalignant oral leukoplakia (OL) are urgently needed. The objective of this study was to examine the expression patterns of cancer stem cell markers ALDH1 and CD133 in samples from patients with OL, and determine their prognostic values for subsequent development of oral cancer. Immunohistochemistry for ALDH1 and CD133 was performed in samples from a cohort of 141 patients with biopsy‐proven OL who received a mean follow‐up of 5.5 years. Patient clinicopathologic and follow‐up data were analyzed. Expression of ALDH1 and CD133 was observed in 54 (38.3%) and 32 (22.7%) of 141 patients with OL, respectively. Kaplan–Meier analysis showed that 48.1% patients with ALDH1‐positivity developed oral cancer compared with 12.6% those with ALDH1‐negativity (p < 0.001). Meanwhile, 59.4% patients with CD133‐positivity developed oral cancer compared with 16.5% those with CD133‐negativity (p < 0.001). Multivariate analysis revealed that ALDH1 and CD133 expression was associated with 4.17‐fold [95% confidence interval (CI), 1.96–8.90; p < 0.001] and 2.86‐fold (95% CI, 1.48‐5.55; p = 0.002) increased risk of OL transformation, respectively. Collectively, these data demonstrated for the first time that the expression of ALDH1 and CD133 correlated with malignant transformation in a large series of patients with OL who received a long‐term follow‐up, which suggests that they may serve as predictors to identify OL with a high risk of oral cancer development.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2015

MicroRNA‐155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential

Linjun Shi; Chen‐Yang Zhang; Zengtong Zhou; Jing‐Yuan Ma; Yang Liu; Zhe-Xuan Bao; Wei‐Wen Jiang

Oral squamous cell carcinoma (OSCC) is a common malignancy with poor prognosis. MicroRNAs (miRNAs) play an important role in cancer, but their role in OSCC is not clarified.


Journal of Oral Pathology & Medicine | 2013

Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer.

Jinqiu Feng; Ziyuan Xu; Linjun Shi; Lan Wu; Wei Liu; Zengtong Zhou

BACKGROUND Oral erythroplakia (OE) is a notoriously aggressive oral pre-malignant lesion with a high tendency to oral cancer development, but its biological behavior is largely unknown. The objective of this study was to determine the expression of cancer stem cell markers ALDH1 and Bmi1 in OE and their correlation with malignant transformation of OE. METHODS In a retrospective case-control study, expression patterns of ALDH1 and Bmi1 were determined using immunohistochemistry in samples from 34 patients with OE, including patients with untransformed lesions (n=17) and patients with malignant transformed lesions (n=17). RESULTS ALDH1 and Bmi1 expression was observed in 19 (55.9%) and 20 (58.8%) of 34 patients with OE, respectively. Multivariate analysis revealed that ALDH1 expression was significantly associated with increased risk of transformation (P<0.05), but Bmi1 expression was not a significant marker (P > 0.05). Notably, the coexpression of both ALDH1 and Bmi1 was a strong indicator associated with 8.56-fold (95% confidence interval [CI], 1.74-42.17; P<0.01) for malignant transformation. Point prevalence analysis revealed that 78.6% (95% CI, 54.0-100) of the patient with coexpression of both ALDH1 and Bmi1 developed oral cancer. CONCLUSION Our data indicated that the expression patterns of ALDH1 and Bmi1 in OE were associated with malignant transformation, suggesting that they may be valuable predictors for evaluating the risk of oral cancer.


Journal of Oral Pathology & Medicine | 2012

A clinicopathological study on verrucous hyperplasia and verrucous carcinoma of the oral mucosa

Laikuan Zhu; Yewei Ding; Wei Liu; Zhou Ym; Linjun Shi; Zengtong Zhou

BACKGROUND Oral verrucous hyperplasia (VH) and verrucous carcinoma (VC) are two clinicopathologically distinctive oral verrucous lesions. The objective of this study was to investigate the clinicopathological features of the two verrucous lesions and estimate their relationship from China. METHODS Retrospective review of two series of patients with histologically confirmed VH (n = 121) and VC (n = 56) between 1996 and 2009 in our hospital were conducted. RESULTS The average age of VH was 58.5 years (ratio male:female = 1.37) with the tongue being the predominant site. The average age of VC was 64.3 years (ratio male:female = 1.15) with the lower lip being the predominant site. Multivariate analysis revealed that the elderly patient with verrucous lesion (≥60 years) was associated with 3.06-fold (P = 0.007) increased carcinoma risk compared with the non-elderly patient. The lesion located on lower lip was associated with 13.54-fold (P < 0.001) increased carcinoma risk compared with other sites. CONCLUSION Clinicopathological features of VH and VC in China were elucidated. Elderly patient with oral verrucous lesion located on the lower lip correlates with higher risk of carcinoma.


Oral Oncology | 2012

Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development

Jinqiu Feng; Jun-Guo Mi; Lan Wu; Liwei Ma; Linjun Shi; Xi Yang; Wei Liu; Chenping Zhang; Zengtong Zhou

Oral erythroplakia (OE) is a notoriously aggressive oral premalignant lesion with a high tendency to oral cancer development, but its biological behavior is largely unknown. The objective of the current study was to determine podoplanin and ABCG2 immunoexpression in OE and both correlation to malignant transformation of OE. In a retrospective follow-up study, the expression patterns of podoplanin and ABCG2 were determined using immunohistochemistry in samples from 34 patients with OE, including patients with untransformed lesions (n=17) and patients with malignant transformed lesions (n=17). Podoplanin and ABCG2 expression was observed in 15 (44.1%) and 21 (61.8%) of 34 patients, respectively. Multivariate analysis revealed that podoplanin and ABCG2 expression was associated with 6.31-fold (95% confidence interval [CI], 1.02-38.92; P=0.047) and 14.39-fold (95% CI, 2.02-102.29; P=0.008) increased the risk of transformation, respectively. Point prevalence analysis revealed that 90.9% (95% CI, 70.7-100) of the patient with both podoplanin and ABCG2 positivity developed oral cancer. Collectively, our data indicated that the expression patterns of podoplanin and ABCG2 in OE were associated with oral cancer development, suggesting that podoplanin and ABCG2 may be valuable predictors for evaluating oral cancer risk.

Collaboration


Dive into the Zengtong Zhou's collaboration.

Top Co-Authors

Avatar

Wei Liu

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Linjun Shi

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Jinqiu Feng

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Xuemin Shen

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Zhengyu Shen

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Lan Wu

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Zhe-Xuan Bao

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Chenping Zhang

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Wei-Wen Jiang

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Liwei Ma

Shanghai Jiao Tong University

View shared research outputs
Researchain Logo
Decentralizing Knowledge